T-lymphocytic infiltrate in canine mammary tumours: Clinic and prognostic implications

In Vivo

Volumn 25, Issue 6, 2011, Pages 963-969

  Carvalho, Maria Isabel ^a   Pires, Isabel ^b   Prada, Justina ^b   Queiroga, Felisbina L ^b  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

Canine mammary tumours; CD3; Dog; Immunohistochemistry; Prognosis; T lymphocytic infiltrate; Tumour

Indexed keywords

CD3 ANTIGEN;

ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER SURVIVAL; CD3+ T LYMPHOCYTE; CLINICAL FEATURE; DOG; FEMALE; LYMPHOCYTIC INFILTRATION; NONHUMAN; OVERALL SURVIVAL; PROGNOSIS; TUMOR ASSOCIATED LEUKOCYTE;

EID: 80755159156     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Sorenmo K: Canine mammary gland tumors. Vet Clin North Am Small Anim Pract 33: 573-596, 2003.
2. Mareel M and Leroy A: Clinical, cellular, and molecular aspects of cancer invasion: Physiol Rev 83: 337-376, 2003. (Pubitemid 36382891)
3. Vanherberghen M, Day MJ, Delvaux F, Gabriel A, Clercx C and Peeters D: An immunohistochemical study of the inflammatory infiltrate associated with nasal carcinoma in dogs and cats. J Comp Pathol 141: 17-26, 2009.
4. O'Neill K, Guth A, Biller B, Elmslie R and Dow S: Changes in regulatory T-cells in dogs with cancer and associations with tumor type. J Vet Intern Med 23: 875-881, 2009.
5. Pérez J, Day MJ and Mozos E: Immunohistochemical study of the local inflammatory infiltrate in spontaneous canine transmissible venereal tumour at different stages of growth. Vet Immunol Immunopathol 64: 133-147, 1998. (Pubitemid 28300277)
6. Trail PA and Yang TJ: Canine transmissible venereal sarcoma: quantitation of T-lymphocyte subpopulations during progressive growth and spontaneous tumor regression. J Natl Cancer Inst 74: 461-467, 1985. (Pubitemid 15112134)
7. Nicholls PK, Moore PF, Anderson DM, Moore RA, Parry NR, Gough GW and Stanley MA: Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes. Virology 283: 31-39, 2001. (Pubitemid 32911506)
8. Cockerell GL and Slauson DO: Patterns of lymphoid infiltrate in the canine cutaneous histiocytoma. J Comp Pathol 89: 193-203, 1979. (Pubitemid 9155856)
9. Pires I, Queiroga FL, Alves A, Silva F and Lopes C: Decrease of E-cadherin expression in canine cutaneous histiocytoma appears to be related to its spontaneous regression. Anticancer Res 29: 2713-2717, 2009.
10. Grieco V, Rondena M, Romussi S, Stefanello D and Finazzi M: Immunohistochemical characterization of the leucocytic infiltrate associated with canine seminomas. J Comp Pathol 130: 278-284, 2004. (Pubitemid 38477279)
11. Ben-Baruch A: Host microenvironment in breast cancer development, Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res 5: 31-36, 2003.
12. Georgiannos SN, Renaut A, Goode AW and Sheaff M: The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators. Surgery 134: 827-834, 2003. (Pubitemid 37523968)
13. Murri AM, Hilmy M, Bell J, Wilson C, McNicol AM, Lannigan A, Doughty JC and McMillan DC: The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. Br J Cancer 99: 1013-1022, 2008.
14. Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E and Syrjänen K: Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer 28A: 859-864, 1992.
15. DeNardo DG and Coussens LM: Inflammation and breast cancer, Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 9: 212-222, 2007.
16. Kuroda H, Tamara J, Sakamoto G, Ohnisi K and Itoyama S: Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast. Virchows Arch 446: 10-14, 2005. (Pubitemid 40179150)
17. + T lymphocytes in early breast cancer reflect lymph node involvement. Clinics 61: 203-208, 2006.
18. Sheu BC, Kuo WH, Chen RJ, Huang SC, Chang KJ and Chow SN: Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer. Breast 17: 604-610, 2008.
19. Kim J-H, Yu C-H, Yhee J-Y, Im K-S and Sur J-H: Lymphocyte infiltration, expression of interleukin (IL)-1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours. J Comp Pathol 142: 177-186, 2010.
20. Misdorp W, Else RW, Hellmen E and Lipscomb TP: Histological classification of mammary tumors of the dog and cat. Washington: Armed Forces Institute of Pathology and the World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology, 1999.
21. Elston CW and Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991.
22. Karayannopoulou M, Kaldrymidou E, Constantinidis TC and Dessiris A: Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method. J Comp Pathol 133: 246-252, 2005. (Pubitemid 41671219)
23. Hussein MR, Al-Assiri M and Musalam AO: Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma. Exp Mol Pathol 86: 108-113, 2009.
24. Bethwaite PB, Holloway LJ, Thornton A and Delahunt B: Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study. Pathology 28: 321-327, 1996. (Pubitemid 27170919)
25. Rajjoub S, Basha SR, Einhorn E, Cohen MC, Marvel DM and Sewell DA: Prognostic significance of tumor-infiltrating lymphocytes in oropharyngeal cancer. Ear Nose Throat J 86: 506-511, 2007. (Pubitemid 351268069)
26. Shimokawara I, Imamura M, Yamanaka N, Ishii Y and Kikuchi K: Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: an immunoperoxidase study with anti-human T- and B-cell sera. Cancer 49: 1456-1464, 1982. (Pubitemid 12143070)
27. Tanaka H, Shimoda T, Uchida K, Suzuki T and Ishikawa E: Immunohistochemical study on the distribution and significance of mononuclear cells in human breast carcinoma. Acta Pathol Jpn 36: 1455-1468, 1986. (Pubitemid 17205916)
28. Campbell MJ, Scott J, Maecker HT, Park JW and Esserman LJ: Immune dysfunction and micrometastases in women with breast cancer. Breast Cancer Res Treat 91: 163-171, 2005. (Pubitemid 40684928)
29. Marsigliante S, Biscozzo L, Marra A, Nicolardi G, Leo G, Lobreglio GB and Storelli C: Computerised counting of tumour infiltrating lymphocytes in 90 breast cancer specimens. Cancer Lett 139: 33-41, 1999. (Pubitemid 29222021)
30. Vieira FLD, Vieira BJ, Guimaraes MAM and Aarestrup FM: Cellular profile of peritumoral inflammatory infiltrate in squamous cells carcinoma of oral mucosa: Correlations with the expression of Ki-67 and histologic grading. BMC Oral Health 8: 25-32, 2008.
31. Ben-Baruch A: Breast cancer progression: A "vicious cycle" of pro-malignancy activities is mediated by inflammatory cells, chemokines and cytokines. In: Cancer Growth and Progression/Integration/Interaction of Oncologic Growth. Springer. The Netherlands, pp. 189-217, 2005.
32. Luboshits G, Shina S, Kaplan O, Engelberg S, Nass D, Lifshitz-Mercer B, Chaitchik S, Keydar I and Ben-Baruch A: Elevated expression of the cc chemokine regulated on activation, normal t cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 59: 4681-4687, 1999. (Pubitemid 29428976)
33. Soria G and Ben-Baruch A: The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett 267: 271-285, 2008.
34. Goede V, Brogelli L, Ziche M and Augustin HG: Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 82: 765-770, 1999. (Pubitemid 29356979)
35. Saji H, Koike M, Yamori T, Saji S, Seiki M, Matsushima K and Toi M: Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer 92: 1085-1091, 2001. (Pubitemid 32861655)
36. Vitiello PF, Shainheit MG, Allison EM, Adler EP and Kurt RA: Impact of tumor-derived CCL2 on T-cell effector function. Immunol Lett 91: 239-245, 2004. (Pubitemid 38296384)
37. Adler EP, Lemken CA, Katchen NS and Kurt RA: A dual role for tumor-derived chemokine RANTES (CCL5). Immunol Lett 90: 187-194, 2003. (Pubitemid 37548476)
38. Balkwill F, Charles KA and Mantovani A: Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7: 211-217, 2005. (Pubitemid 40568680)